Alembic Pharmaceuticals Limited (BOM: 533573)
India
· Delayed Price · Currency is INR 1,055.00
0.00 (0.00%)
At close: Dec 20, 2024
Alembic Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 207,404 | 193,575 | 97,564 | 145,771 | 189,674 | 100,715 | Upgrade
|
| Market Cap Growth | 53.67% | 98.41% | -33.07% | -23.15% | 88.33% | -0.66% | Upgrade
|
| Enterprise Value | 216,773 | 200,785 | 104,548 | 151,109 | 193,139 | 115,147 | Upgrade
|
| Last Close Price | 1055.00 | 971.38 | 485.05 | 714.04 | 916.17 | 506.57 | Upgrade
|
| PE Ratio | 32.07 | 31.43 | 28.53 | 27.98 | 16.54 | 12.15 | Upgrade
|
| PS Ratio | 3.73 | 3.11 | 1.73 | 2.75 | 3.52 | 2.19 | Upgrade
|
| PB Ratio | 4.85 | 4.02 | 2.23 | 2.78 | 3.74 | 3.16 | Upgrade
|
| P/TBV Ratio | 4.85 | 4.02 | 2.23 | 2.87 | 4.00 | 3.45 | Upgrade
|
| P/FCF Ratio | 292.14 | 40.69 | 34.78 | 115.04 | 23.60 | - | Upgrade
|
| P/OCF Ratio | 57.90 | 24.10 | 13.48 | 26.39 | 12.96 | 22.42 | Upgrade
|
| EV/Sales Ratio | 3.41 | 3.22 | 1.85 | 2.85 | 3.58 | 2.50 | Upgrade
|
| EV/EBITDA Ratio | 21.61 | 21.97 | 15.02 | 17.60 | 13.17 | 9.18 | Upgrade
|
| EV/EBIT Ratio | 29.91 | 30.39 | 23.88 | 25.72 | 14.89 | 10.36 | Upgrade
|
| EV/FCF Ratio | 267.26 | 42.21 | 37.27 | 119.26 | 24.03 | - | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.11 | 0.17 | 0.14 | 0.12 | 0.57 | Upgrade
|
| Debt / EBITDA Ratio | 1.06 | 0.55 | 1.01 | 0.82 | 0.39 | 1.44 | Upgrade
|
| Debt / FCF Ratio | 13.15 | 1.08 | 2.57 | 5.66 | 0.73 | - | Upgrade
|
| Asset Turnover | 0.93 | 0.99 | 0.85 | 0.77 | 0.85 | 0.86 | Upgrade
|
| Inventory Turnover | 0.98 | 1.15 | 1.15 | 0.97 | 1.00 | 1.01 | Upgrade
|
| Quick Ratio | 0.66 | 0.82 | 0.74 | 0.52 | 0.51 | 0.55 | Upgrade
|
| Current Ratio | 1.73 | 2.12 | 1.78 | 1.67 | 2.07 | 1.41 | Upgrade
|
| Return on Equity (ROE) | 13.81% | 13.40% | 7.12% | 10.11% | 27.77% | 27.10% | Upgrade
|
| Return on Assets (ROA) | 6.61% | 6.54% | 4.11% | 5.31% | 12.77% | 12.90% | Upgrade
|
| Return on Capital (ROIC) | 8.01% | 7.92% | 4.95% | 6.33% | 15.19% | 15.67% | Upgrade
|
| Earnings Yield | 3.12% | 3.18% | 3.51% | 3.57% | 6.04% | 8.23% | Upgrade
|
| FCF Yield | 0.34% | 2.46% | 2.88% | 0.87% | 4.24% | -2.84% | Upgrade
|
| Dividend Yield | 0.00% | 1.13% | 1.65% | 1.40% | 1.53% | 1.38% | Upgrade
|
| Payout Ratio | 33.43% | 25.54% | 57.48% | 52.83% | - | 28.43% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | - | - | -1.46% | -2.77% | - | Upgrade
|
| Total Shareholder Return | -0.08% | 1.13% | 1.65% | -0.06% | -1.24% | 1.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.